Trial Profile
Atorvastatin Reduces Malondialdehyde Concentrations in Patients with Polycystic Ovary Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 10 Sep 2012 New trial record